Subscribe to RSS
DOI: 10.1055/s-0039-3400242
Kisspeptin and Glucose Homeostasis
Publication History
Publication Date:
23 December 2019 (online)
![](https://www.thieme-connect.de/media/srm/201903/lookinside/thumbnails/10-1055-s-0039-3400242_001156-1.jpg)
Abstract
Kisspeptin has well-established critical roles in the control of reproduction and fertility. Recently, evidence has emerged that suggests kisspeptin may have additional roles in the regulation of glucose homeostasis. Conflicting reports on the effects of kisspeptin on insulin secretion in animal models have been published, which cannot be fully accounted for by the different kisspeptin isoforms and range of kisspeptin doses used in these studies. Human studies have demonstrated associations between circulating kisspeptin levels and measures of insulin secretion and insulin resistance; and the only published interventional study has confirmed kisspeptin enhances glucose-stimulated insulin secretion in humans. Further studies are required to elucidate the mechanisms underlying the effects of kisspeptin on the pancreatic β-cell and to determine the therapeutic potential of kisspeptin receptor agonist in the treatment of disorders of glucose homeostasis.
-
References
- 1 Seminara SB, Messager S, Chatzidaki EE. , et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003; 349 (17) 1614-1627
- 2 Silveira LG, Noel SD, Silveira-Neto AP. , et al. Mutations of the KISS1 gene in disorders of puberty. J Clin Endocrinol Metab 2010; 95 (05) 2276-2280
- 3 Teles MG, Bianco SD, Brito VN. , et al. A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 2008; 358 (07) 709-715
- 4 de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A 2003; 100 (19) 10972-10976
- 5 Keen KL, Wegner FH, Bloom SR, Ghatei MA, Terasawa E. An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalk-median eminence of female rhesus monkeys in vivo. Endocrinology 2008; 149 (08) 4151-4157
- 6 Navarro VM, Fernández-Fernández R, Castellano JM. , et al. Advanced vaginal opening and precocious activation of the reproductive axis by KiSS-1 peptide, the endogenous ligand of GPR54. J Physiol 2004; 561 (Pt 2): 379-386
- 7 Nestor CC, Briscoe AM, Davis SM, Valent M, Goodman RL, Hileman SM. Evidence of a role for kisspeptin and neurokinin B in puberty of female sheep. Endocrinology 2012; 153 (06) 2756-2765
- 8 Pineda R, Garcia-Galiano D, Roseweir A. , et al. Critical roles of kisspeptins in female puberty and preovulatory gonadotropin surges as revealed by a novel antagonist. Endocrinology 2010; 151 (02) 722-730
- 9 Redmond JS, Macedo GG, Velez IC, Caraty A, Williams GL, Amstalden M. Kisspeptin activates the hypothalamic-adenohypophyseal-gonadal axis in prepubertal ewe lambs. Reproduction 2011; 141 (04) 541-548
- 10 Dudek M, Kołodziejski PA, Pruszyńska-Oszmałek E. , et al. Effects of high-fat diet-induced obesity and diabetes on Kiss1 and GPR54 expression in the hypothalamic-pituitary-gonadal (HPG) axis and peripheral organs (fat, pancreas and liver) in male rats. Neuropeptides 2016; 56: 41-49
- 11 Kostakis ID, Agrogiannis G, Vaiopoulos AG. , et al. KISS1 and KISS1R expression in gastric cancer. J BUON 2018; 23 (01) 79-84
- 12 Kotani M, Detheux M, Vandenbogaerde A. , et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 2001; 276 (37) 34631-34636
- 13 Lee DK, Nguyen T, O'Neill GP. , et al. Discovery of a receptor related to the galanin receptors. FEBS Lett 1999; 446 (01) 103-107
- 14 Muir AI, Chamberlain L, Elshourbagy NA. , et al. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 2001; 276 (31) 28969-28975
- 15 Ohtaki T, Shintani Y, Honda S. , et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 2001; 411 (6837): 613-617
- 16 Colledge WH. Transgenic mouse models to study Gpr54/kisspeptin physiology. Peptides 2009; 30 (01) 34-41
- 17 Lapatto R, Pallais JC, Zhang D. , et al. Kiss1-/- mice exhibit more variable hypogonadism than Gpr54-/- mice. Endocrinology 2007; 148 (10) 4927-4936
- 18 Velasco I, León S, Barroso A. , et al. Gonadal hormone-dependent vs. -independent effects of kisspeptin signaling in the control of body weight and metabolic homeostasis. Metabolism 2019; 98: 84-94
- 19 Tolson KP, Marooki N, Wolfe A, Smith JT, Kauffman AS. Cre/lox generation of a novel whole-body Kiss1r KO mouse line recapitulates a hypogonadal, obese, and metabolically-impaired phenotype. Mol Cell Endocrinol 2019; 498: 110559
- 20 Tolson KP, Garcia C, Yen S. , et al. Impaired kisspeptin signaling decreases metabolism and promotes glucose intolerance and obesity. J Clin Invest 2014; 124 (07) 3075-3079
- 21 Tolson KP, Garcia C, Delgado I, Marooki N, Kauffman AS. Metabolism and energy expenditure, but not feeding or glucose tolerance, are impaired in young Kiss1r KO female mice. Endocrinology 2016; 157 (11) 4192-4199
- 22 Izzi-Engbeaya C, Comninos AN, Clarke SA. , et al. The effects of kisspeptin on β-cell function, serum metabolites and appetite in humans. Diabetes Obes Metab 2018; 20 (12) 2800-2810
- 23 Hauge-Evans AC, Richardson CC, Milne HM, Christie MR, Persaud SJ, Jones PM. A role for kisspeptin in islet function. Diabetologia 2006; 49 (09) 2131-2135
- 24 Song WJ, Mondal P, Wolfe A. , et al. Glucagon regulates hepatic kisspeptin to impair insulin secretion. Cell Metab 2014; 19 (04) 667-681
- 25 Chen J, Fu R, Cui Y. , et al. LIM-homeodomain transcription factor Isl-1 mediates kisspeptin's effect on insulin secretion in mice. Mol Endocrinol 2014; 28 (08) 1276-1290
- 26 Schwetz TA, Reissaus CA, Piston DW. Differential stimulation of insulin secretion by GLP-1 and Kisspeptin-10. PLoS One 2014; 9 (11) e113020
- 27 Bowe JE, Chander A, Liu B, Persaud SJ, Jones PM. The permissive effects of glucose on receptor-operated potentiation of insulin secretion from mouse islets: a role for ERK1/2 activation and cytoskeletal remodelling. Diabetologia 2013; 56 (04) 783-791
- 28 Bowe JE, King AJ, Kinsey-Jones JS. , et al. Kisspeptin stimulation of insulin secretion: mechanisms of action in mouse islets and rats. Diabetologia 2009; 52 (05) 855-862
- 29 Vikman J, Ahrén B. Inhibitory effect of kisspeptins on insulin secretion from isolated mouse islets. Diabetes Obes Metab 2009; 11 (Suppl. 04) 197-201
- 30 Silvestre RA, Egido EM, Hernández R, Marco J. Kisspeptin-13 inhibits insulin secretion without affecting glucagon or somatostatin release: study in the perfused rat pancreas. J Endocrinol 2008; 196 (02) 283-290
- 31 Bilban M, Ghaffari-Tabrizi N, Hintermann E. , et al. Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci 2004; 117 (Pt 8): 1319-1328
- 32 Bowe JE, Foot VL, Amiel SA. , et al. GPR54 peptide agonists stimulate insulin secretion from murine, porcine and human islets. Islets 2012; 4 (01) 20-23
- 33 Wolfe A, Hussain MA. The emerging role(s) for kisspeptin in metabolism in mammals. Front Endocrinol (Lausanne) 2018; 9: 184
- 34 Amisten S, Salehi A, Rorsman P, Jones PM, Persaud SJ. An atlas and functional analysis of G-protein coupled receptors in human islets of Langerhans. Pharmacol Ther 2013; 139 (03) 359-391
- 35 Billington CK, Penn RB. Signaling and regulation of G protein-coupled receptors in airway smooth muscle. Respir Res 2003; 4: 2
- 36 Rosengren AH, Jokubka R, Tojjar D. , et al. Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science 2010; 327 (5962): 217-220
- 37 Ringel MD, Hardy E, Bernet VJ. , et al. Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab 2002; 87 (05) 2399
- 38 Masui T, Doi R, Mori T. , et al. Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochem Biophys Res Commun 2004; 315 (01) 85-92
- 39 Wahab F, Riaz T, Shahab M. Study on the effect of peripheral kisspeptin administration on basal and glucose-induced insulin secretion under fed and fasting conditions in the adult male rhesus monkey (Macaca mulatta). Horm Metab Res 2011; 43 (01) 37-42
- 40 Cetković A, Miljic D, Ljubić A. , et al. Plasma kisspeptin levels in pregnancies with diabetes and hypertensive disease as a potential marker of placental dysfunction and adverse perinatal outcome. Endocr Res 2012; 37 (02) 78-88
- 41 Andreozzi F, Mannino GC, Mancuso E, Spiga R, Perticone F, Sesti G. Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals. PLoS One 2017; 12 (06) e0179834
- 42 Lorenzo C, Wagenknecht LE, Rewers MJ. , et al. Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010; 33 (09) 2098-2103
- 43 Dhillo WS, Chaudhri OB, Patterson M. , et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab 2005; 90 (12) 6609-6615
- 44 Dhillo WS, Chaudhri OB, Thompson EL. , et al. Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J Clin Endocrinol Metab 2007; 92 (10) 3958-3966
- 45 Navarro G, Xu W, Jacobson DA. , et al. Extranuclear actions of the androgen receptor enhance glucose-stimulated insulin secretion in the male. Cell Metab 2016; 23 (05) 837-851
- 46 Wong WP, Tiano JP, Liu S. , et al. Extranuclear estrogen receptor-alpha stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis. Proc Natl Acad Sci U S A 2010; 107 (29) 13057-13062
- 47 Sharma G, Prossnitz ER. Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells. Endocrinology 2011; 152 (08) 3030-3039
- 48 Dandona P, Dhindsa S. Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab 2011; 96 (09) 2643-2651
- 49 Niswender CM, Willis BS, Wallen A. , et al. Cre recombinase-dependent expression of a constitutively active mutant allele of the catalytic subunit of protein kinase A. Genesis 2005; 43 (03) 109-119
- 50 Ahrén B, Larsson H. Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations. Diabetologia 2001; 44 (11) 1998-2003
- 51 Baron AD, Schaeffer L, Shragg P, Kolterman OG. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes 1987; 36 (03) 274-283
- 52 Wang T, Han S, Tian W, Zhao M, Zhang H. Effects of kisspeptin on pathogenesis and energy metabolism in polycystic ovarian syndrome (PCOS). Gynecol Endocrinol 2019; 35 (09) 807-810
- 53 Horikoshi Y, Matsumoto H, Takatsu Y. , et al. Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab 2003; 88 (02) 914-919
- 54 Jayasena CN, Abbara A, Izzi-Engbeaya C. , et al. Reduced levels of plasma kisspeptin during the antenatal booking visit are associated with increased risk of miscarriage. J Clin Endocrinol Metab 2014; 99 (12) E2652-E2660
- 55 Herreboudt AM, Kyle VR, Lawrence J, Doran J, Colledge WH. Kiss1 mutant placentas show normal structure and function in the mouse. Placenta 2015; 36 (01) 52-58
- 56 Oride A, Kanasaki H, Mijiddorj T, Sukhbaatar U, Ishihara T, Kyo S. Regulation of kisspeptin and gonadotropin-releasing hormone expression in rat placenta: study using primary cultures of rat placental cells. Reprod Biol Endocrinol 2015; 13: 90
- 57 Schäfer-Somi S, Ay SS, Kaya D. , et al. Kisspeptin-10 and the G protein-coupled receptor 54 are differentially expressed in the canine pregnant uterus and trophoblast cells. Reprod Domest Anim 2017; 52 (Suppl. 02) 123-129
- 58 Ryan EA. Hormones and insulin resistance during pregnancy. Lancet 2003; 362 (9398): 1777-1778
- 59 Bowe JE, Hill TG, Hunt KF. , et al. A role for placental kisspeptin in β-cell adaptation to pregnancy. JCI Insight 2019; 4 (20) pii 124540